News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
275,460 Results
Type
Article (14322)
Company Profile (101)
Press Release (261028)
Multimedia
Podcasts (67)
Webinars (14)
Section
Business (88377)
Career Advice (466)
Deals (15404)
Drug Delivery (76)
Drug Development (36848)
Employer Resources (50)
FDA (6401)
Job Trends (6235)
News (150953)
Policy (14145)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (444)
Accelerated approval (15)
Adcomms (8)
Allergies (82)
Alliances (23333)
ALS (63)
Alzheimer's disease (494)
Antibody-drug conjugate (ADC) (111)
Approvals (6621)
Artificial intelligence (222)
Autoimmune disease (58)
Automation (15)
Bankruptcy (150)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (126)
Biotechnology (39)
Bladder cancer (44)
Brain cancer (34)
Breast cancer (182)
Cancer (1436)
Cardiovascular disease (171)
Career advice (419)
Career pathing (13)
CAR-T (53)
CDC (6)
Cell therapy (166)
Cervical cancer (12)
Clinical research (32275)
Collaboration (793)
Compensation (346)
Complete response letters (41)
COVID-19 (781)
CRISPR (46)
C-suite (498)
Cystic fibrosis (59)
Data (2022)
Denatured (18)
Depression (51)
Diabetes (136)
Diagnostics (1420)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (132)
Drug pricing (116)
Drug shortages (12)
Duchenne muscular dystrophy (89)
Earnings (33804)
Editorial (22)
Employer branding (4)
Employer resources (46)
Events (39300)
Executive appointments (559)
FDA (7586)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (474)
Gene editing (75)
Generative AI (20)
Gene therapy (180)
GLP-1 (453)
Government (1415)
Grass and pollen (4)
Guidances (168)
Healthcare (3590)
HIV (15)
Huntington's disease (9)
IgA nephropathy (42)
Immunology and inflammation (73)
Immuno-oncology (19)
Indications (69)
Infectious disease (859)
Inflammatory bowel disease (82)
Inflation Reduction Act (7)
Influenza (26)
Intellectual property (118)
Interviews (60)
IPO (5917)
IRA (33)
Job creations (2057)
Job search strategy (374)
JPM (29)
Kidney cancer (10)
Labor market (29)
Layoffs (206)
Leadership (8)
Legal (3449)
Liver cancer (23)
Longevity (8)
Lung cancer (194)
Lymphoma (133)
Machine learning (13)
Management (17)
Manufacturing (451)
MASH (76)
Medical device (1309)
Medtech (1320)
Mergers & acquisitions (9931)
Metabolic disorders (482)
mRNA (53)
Multiple sclerosis (52)
NASH (15)
Neurodegenerative disease (93)
Neuropsychiatric disorders (40)
Neuroscience (943)
Neurotech (1)
NextGen: Class of 2026 (1591)
Non-profit (605)
Now hiring (20)
Obesity (253)
Opinion (145)
Ovarian cancer (43)
Pain (120)
Pancreatic cancer (55)
Parkinson's disease (91)
Partnered (11)
Patents (238)
Patient recruitment (134)
Peanut (15)
People (29897)
Pharmaceutical (60)
Pharmacy benefit managers (18)
Phase 1 (8380)
Phase 2 (13642)
Phase 3 (12293)
Pipeline (2412)
Policy (142)
Postmarket research (1403)
Preclinical (3373)
Press Release (25)
Prostate cancer (93)
Psychedelics (17)
Radiopharmaceuticals (142)
Rare diseases (399)
Real estate (2659)
Recruiting (19)
Regulatory (11095)
Reports (15)
Research institute (580)
Resumes & cover letters (56)
Rett syndrome (7)
RNA editing (6)
RSV (21)
Schizophrenia (74)
Series A (91)
Series B (56)
Service/supplier (2)
Sickle cell disease (48)
Special edition (10)
Spinal muscular atrophy (82)
Sponsored (9)
Startups (1648)
State (2)
Stomach cancer (6)
Supply chain (52)
Tariffs (68)
The Weekly (47)
Vaccines (243)
Venture capital (34)
Weight loss (148)
Women's health (35)
Worklife (4)
Date
Today (5)
Last 7 days (204)
Last 30 days (931)
Last 365 days (10318)
2026 (2267)
2025 (10721)
2024 (12528)
2023 (14270)
2022 (19585)
2021 (20091)
2020 (19046)
2019 (14897)
2018 (11726)
2017 (13902)
2016 (13152)
2015 (15507)
2014 (12435)
2013 (10621)
2012 (11399)
2011 (11929)
2010 (10891)
Location
Africa (319)
Alabama (19)
Alaska (1)
Arizona (80)
Arkansas (4)
Asia (20998)
Australia (2706)
California (3424)
Canada (1576)
China (596)
Colorado (152)
Connecticut (136)
Delaware (133)
Europe (41148)
Florida (648)
Georgia (67)
Hawaii (1)
Idaho (10)
Illinois (381)
India (48)
Indiana (260)
Iowa (2)
Japan (273)
Kansas (79)
Kentucky (21)
Louisiana (4)
Maine (2)
Maryland (455)
Massachusetts (2781)
Michigan (47)
Minnesota (178)
Mississippi (1)
Missouri (36)
Montana (9)
Nebraska (8)
Nevada (17)
New Hampshire (8)
New Jersey (1515)
New Mexico (7)
New York (971)
North Carolina (653)
North Dakota (2)
Northern California (1580)
Ohio (83)
Oklahoma (5)
Oregon (18)
Pennsylvania (766)
Puerto Rico (14)
Rhode Island (18)
South America (508)
South Carolina (10)
Southern California (1502)
Tennessee (56)
Texas (489)
United States (13612)
Utah (62)
Virginia (176)
Washington D.C. (42)
Washington State (241)
West Virginia (1)
Wisconsin (40)
Wyoming (1)
275,460 Results for "mgc pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation
MGC Pharmaceuticals Ltd, Rebrands as Argent BioPharma in Strategic Transformation Marking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders.
February 13, 2024
·
3 min read
MGC Pharma’s CannEpil® Now Accessible to UK Patients on Named Patient Request Basis
MGC Pharmaceuticals Ltd., announces that its proprietary product CannEpil® is now available to patients in the UK by Named Patient Request.
April 11, 2023
·
3 min read
Deals
CAIRE® to Acquire MGC Diagnostics Holdings, Inc.
Portfolio Expands to Include Non-Invasive Cardiorespiratory Diagnostic Systems CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. MGC designs, develops, manufactures, and markets non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease.
November 29, 2022
·
3 min read
Press Releases
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
March 9, 2026
·
11 min read
Deals
Altus Capital Partners-Backed MGC Diagnostics Corporation Acquires Lemon Medical, GmbH
MGC Diagnostics Corporation (“MGC”), a global medical technology company dedicated to cardiorespiratory health solutions, and a portfolio company of Altus Capital Partners, Inc. (“Altus”), announced today the acquisition of Lemon Medical, GmbH.
November 22, 2021
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Director Dealing
March 19, 2026
·
3 min read
Press Releases
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
March 20, 2026
·
11 min read
Press Releases
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
March 4, 2026
·
1 min read
Press Releases
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
March 18, 2026
·
3 min read
Press Releases
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
February 9, 2026
·
5 min read
1 of 27,546
Next
